{"id":35135,"date":"2023-08-07T12:00:00","date_gmt":"2023-08-07T12:00:00","guid":{"rendered":"https:\/\/www.euforea.org\/news\/commentaar-van-euforea-op-misleidend-rapport-over-allergische-rinitis\/"},"modified":"2023-08-07T12:00:00","modified_gmt":"2023-08-07T12:00:00","slug":"commentaar-van-euforea-op-misleidend-rapport-over-allergische-rinitis","status":"publish","type":"news","link":"https:\/\/www.euforea.org\/nl\/news\/commentaar-van-euforea-op-misleidend-rapport-over-allergische-rinitis\/","title":{"rendered":"Commentaar van EUFOREA op misleidend rapport over allergische rinitis"},"content":{"rendered":"<div class=\"paragraph paragraph--text-columns paragraph-id--2306 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<p>In dit artikel bieden leden van het EUFOREA Allergic Rhinitis Expert Panel een kritische analyse van de studie getiteld \u201ePatient Satisfaction and Sensory Attributes of Nasal Spray Treatments of Olopatadine Hydrochloride\/Mometasone Furoate Monohydrate and Azelastine Hydrochloride\/Fluticasone Propionate for Allergic Rhinitis in Australia \u2013 An Observational Real-World Clinical Study&#8221;, gepubliceerd in Patient Preference and Adherence.<\/p>\n<p>Geleid door het uitgangspunt van het zoeken naar nieuw bewijs voor de werkzaamheid en aanvaardbaarheid van rinitisbehandelingen, wat de ambitie van EUFOREA weerspiegelt om de therapie van chronische luchtwegaandoeningen te optimaliseren, hebben wij het concept, de uitvoering en de conclusies ervan besproken.<\/p>\n<p><strong>Co-auteurs:<\/strong> Glenis Scadding, Peter Hellings en Pete Smith.<\/p>\n<p><span class=\"button-ckeditor button-ckeditor--blue\"><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC10395507\/\" target=\"_blank\"><strong>Lees nu<\/strong><\/a><\/span><\/p>\n<\/div><\/div>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>In dit artikel bieden leden van het EUFOREA Allergic Rhinitis Expert Panel een kritische analyse van de studie getiteld \u201ePatient Satisfaction and Sensory Attributes of Nasal Spray Treatments of Olopatadine Hydrochloride\/Mometasone Furoate Monohydrate and Azelastine Hydrochloride\/Fluticasone Propionate for Allergic Rhinitis in Australia \u2013 An Observational Real-World Clinical Study&#8221;, gepubliceerd in Patient Preference and Adherence. Geleid door het uitgangspunt van het zoeken naar nieuw bewijs voor de werkzaamheid en aanvaardbaarheid van rinitisbehandelingen, wat de ambitie van EUFOREA weerspiegelt om de therapie van chronische luchtwegaandoeningen te optimaliseren, hebben wij het concept, de uitvoering en de conclusies ervan besproken. Co-auteurs: Glenis Scadding, Peter Hellings en Pete Smith. Lees nu<\/p>\n","protected":false},"author":1,"featured_media":35140,"comment_status":"open","ping_status":"closed","template":"","meta":{"footnotes":""},"categories":[267],"tags":[154,164,275],"class_list":["post-35135","news","type-news","status-publish","has-post-thumbnail","hentry","category-publicaties","tag-zorgverleners","tag-allergische-rhinitis-ar","tag-publicaties"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.5 (Yoast SEO v28.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Commentaar van EUFOREA op misleidend rapport over allergische rinitis - EUFOREA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.euforea.org\/news\/commentaar-van-euforea-op-misleidend-rapport-over-allergische-rinitis\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Commentaar van EUFOREA op misleidend rapport over allergische rinitis\" \/>\n<meta property=\"og:description\" content=\"In dit artikel bieden leden van het EUFOREA Allergic Rhinitis Expert Panel een kritische analyse van de studie getiteld \u201ePatient Satisfaction and Sensory Attributes of Nasal Spray Treatments of Olopatadine Hydrochloride\/Mometasone Furoate Monohydrate and Azelastine Hydrochloride\/Fluticasone Propionate for Allergic Rhinitis in Australia \u2013 An Observational Real-World Clinical Study&#8221;, gepubliceerd in Patient Preference and Adherence. Geleid door het uitgangspunt van het zoeken naar nieuw bewijs voor de werkzaamheid en aanvaardbaarheid van rinitisbehandelingen, wat de ambitie van EUFOREA weerspiegelt om de therapie van chronische luchtwegaandoeningen te optimaliseren, hebben wij het concept, de uitvoering en de conclusies ervan besproken. Co-auteurs: Glenis Scadding, Peter Hellings en Pete Smith. Lees nu\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.euforea.org\/news\/commentaar-van-euforea-op-misleidend-rapport-over-allergische-rinitis\/\" \/>\n<meta property=\"og:site_name\" content=\"EUFOREA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/euforea\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@euforea\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/commentaar-van-euforea-op-misleidend-rapport-over-allergische-rinitis\\\/\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/commentaar-van-euforea-op-misleidend-rapport-over-allergische-rinitis\\\/\",\"name\":\"Commentaar van EUFOREA op misleidend rapport over allergische rinitis - EUFOREA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/commentaar-van-euforea-op-misleidend-rapport-over-allergische-rinitis\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/commentaar-van-euforea-op-misleidend-rapport-over-allergische-rinitis\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/EUFOREA20Comment20on20Misleading20Allergic20Rhinitis20Report20Teaser.png\",\"datePublished\":\"2023-08-07T12:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/commentaar-van-euforea-op-misleidend-rapport-over-allergische-rinitis\\\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.euforea.org\\\/news\\\/commentaar-van-euforea-op-misleidend-rapport-over-allergische-rinitis\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/commentaar-van-euforea-op-misleidend-rapport-over-allergische-rinitis\\\/#primaryimage\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/EUFOREA20Comment20on20Misleading20Allergic20Rhinitis20Report20Teaser.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/EUFOREA20Comment20on20Misleading20Allergic20Rhinitis20Report20Teaser.png\",\"width\":1748,\"height\":1015},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/commentaar-van-euforea-op-misleidend-rapport-over-allergische-rinitis\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/kies-uw-traject\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Commentaar van EUFOREA op misleidend rapport over allergische rinitis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#website\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/\",\"name\":\"EUFOREA\",\"description\":\"Inspiring the Future of Respiratory Care\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.euforea.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#organization\",\"name\":\"EUFOREA\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"width\":500,\"height\":500,\"caption\":\"EUFOREA\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/euforea\\\/\",\"https:\\\/\\\/x.com\\\/euforea\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/euforea\",\"https:\\\/\\\/www.youtube.com\\\/c\\\/EUFOREA\",\"https:\\\/\\\/www.instagram.com\\\/euforeaofficial\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Commentaar van EUFOREA op misleidend rapport over allergische rinitis - EUFOREA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.euforea.org\/news\/commentaar-van-euforea-op-misleidend-rapport-over-allergische-rinitis\/","og_locale":"nl_NL","og_type":"article","og_title":"Commentaar van EUFOREA op misleidend rapport over allergische rinitis","og_description":"In dit artikel bieden leden van het EUFOREA Allergic Rhinitis Expert Panel een kritische analyse van de studie getiteld \u201ePatient Satisfaction and Sensory Attributes of Nasal Spray Treatments of Olopatadine Hydrochloride\/Mometasone Furoate Monohydrate and Azelastine Hydrochloride\/Fluticasone Propionate for Allergic Rhinitis in Australia \u2013 An Observational Real-World Clinical Study&#8221;, gepubliceerd in Patient Preference and Adherence. Geleid door het uitgangspunt van het zoeken naar nieuw bewijs voor de werkzaamheid en aanvaardbaarheid van rinitisbehandelingen, wat de ambitie van EUFOREA weerspiegelt om de therapie van chronische luchtwegaandoeningen te optimaliseren, hebben wij het concept, de uitvoering en de conclusies ervan besproken. Co-auteurs: Glenis Scadding, Peter Hellings en Pete Smith. Lees nu","og_url":"https:\/\/www.euforea.org\/news\/commentaar-van-euforea-op-misleidend-rapport-over-allergische-rinitis\/","og_site_name":"EUFOREA","article_publisher":"https:\/\/www.facebook.com\/euforea\/","twitter_card":"summary_large_image","twitter_site":"@euforea","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.euforea.org\/news\/commentaar-van-euforea-op-misleidend-rapport-over-allergische-rinitis\/","url":"https:\/\/www.euforea.org\/news\/commentaar-van-euforea-op-misleidend-rapport-over-allergische-rinitis\/","name":"Commentaar van EUFOREA op misleidend rapport over allergische rinitis - EUFOREA","isPartOf":{"@id":"https:\/\/www.euforea.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.euforea.org\/news\/commentaar-van-euforea-op-misleidend-rapport-over-allergische-rinitis\/#primaryimage"},"image":{"@id":"https:\/\/www.euforea.org\/news\/commentaar-van-euforea-op-misleidend-rapport-over-allergische-rinitis\/#primaryimage"},"thumbnailUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/EUFOREA20Comment20on20Misleading20Allergic20Rhinitis20Report20Teaser.png","datePublished":"2023-08-07T12:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.euforea.org\/news\/commentaar-van-euforea-op-misleidend-rapport-over-allergische-rinitis\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.euforea.org\/news\/commentaar-van-euforea-op-misleidend-rapport-over-allergische-rinitis\/"]}]},{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/www.euforea.org\/news\/commentaar-van-euforea-op-misleidend-rapport-over-allergische-rinitis\/#primaryimage","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/EUFOREA20Comment20on20Misleading20Allergic20Rhinitis20Report20Teaser.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/EUFOREA20Comment20on20Misleading20Allergic20Rhinitis20Report20Teaser.png","width":1748,"height":1015},{"@type":"BreadcrumbList","@id":"https:\/\/www.euforea.org\/news\/commentaar-van-euforea-op-misleidend-rapport-over-allergische-rinitis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.euforea.org\/nl\/kies-uw-traject\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.euforea.org\/news\/"},{"@type":"ListItem","position":3,"name":"Commentaar van EUFOREA op misleidend rapport over allergische rinitis"}]},{"@type":"WebSite","@id":"https:\/\/www.euforea.org\/#website","url":"https:\/\/www.euforea.org\/","name":"EUFOREA","description":"Inspiring the Future of Respiratory Care","publisher":{"@id":"https:\/\/www.euforea.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.euforea.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Organization","@id":"https:\/\/www.euforea.org\/#organization","name":"EUFOREA","url":"https:\/\/www.euforea.org\/","logo":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/www.euforea.org\/#\/schema\/logo\/image\/","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","width":500,"height":500,"caption":"EUFOREA"},"image":{"@id":"https:\/\/www.euforea.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/euforea\/","https:\/\/x.com\/euforea","https:\/\/www.linkedin.com\/company\/euforea","https:\/\/www.youtube.com\/c\/EUFOREA","https:\/\/www.instagram.com\/euforeaofficial\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/news\/35135","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/comments?post=35135"}],"version-history":[{"count":0,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/news\/35135\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/media\/35140"}],"wp:attachment":[{"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/media?parent=35135"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/categories?post=35135"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/tags?post=35135"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}